EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression

Tayyaba Zulfiqar, Muhammad Khalid Tipu, Muhammad Tariq Khan, Amr S Abouzied iD, Bassam S M Al Kazman, Saud O Alshammari, Qamar A Alshammari, Abdulkarim Alshammari, Muhammad Nasir Hayat Malik iD, Amir Ali, Muhammad Usama Mazhar iD, Hafsa Jabeen

PLOS One · 2025

DOI: 10.1371/journal.pone.0324060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Tayyaba Zulfiqar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Probiotics, Pediococcus acidilactici, Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysbiosis of gut microbiota and loss of gut-barrier integrity contribute to the development and severity of rheumatoid arthritis (RA). The available treatments pose a burden of major adverse effects and new treatment strategies are therefore the need of time. In this study, Pediococcus acidilactici NMCC-B (Probiotic) was evaluated for its safety and efficacy in complete Freund’s adjuvant (CFA)-induced mice model of RA. Mice were treated with either Escherichia coli (1 × 10 9 CFU/ml) or P. acidilactici NMCC-B (1 × 10 9 CFU/ml, 2 × 10 9 CFU/ml) to assess acute, sub-acute, and chronic toxicities. In RA model, mice were either pre-treated with daily dose of P. acidilactici NMCC-B or treated concurrently (day 1–day 27) or post-treated (day 28–day 42). P. acidilactici NMCC-B inhibited gut permeability, lessened joint inflammation, and ameliorated RA progression. No signs of toxicity, pathogenicity or bacterial translocation were observed in animals treated with probiotic. P. acidilactici NMCC-B also restored total body weight, attenuated inflammation, improved antioxidants, alleviated soft tissue swelling, bone damage, and the expression of IL-1β, NF-κB and TNF-α in paw tissue. Based on current findings, it is perceivable that P. acidilactici NMCC-B could be a promising candidate for the management of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsPediococcus acidilacticiArthritis, RheumatoidArthritis, ExperimentalAnimalsMiceDisease ProgressionGastrointestinal MicrobiomeMaleDisease Models, AnimalFreund's Adjuvant

Substanzen

Freund's Adjuvant

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
  • Department of Pharmacognosy, College of Pharmacy, Najran University, Najran, Saudi Arabia.
  • Department of Pharmacognosy and Alternative Medicine, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Pharmacy Practice, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.

ORCID-Profile: Amr S Abouzied, Muhammad Nasir Hayat Malik, Muhammad Usama Mazhar

Zitieren

APA

Zulfiqar, T., Tipu, M. K., Khan, M. T., Abouzied, A. S., Al Kazman, B. S. M., Alshammari, S. O., Alshammari, Q. A., Alshammari, A., Malik, M. N. H., Ali, A., Mazhar, M. U., & Jabeen, H. (2025). Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression. PLOS One. https://doi.org/10.1371/journal.pone.0324060

Vancouver

Zulfiqar T, Tipu MK, Khan MT, Abouzied AS, Al Kazman BSM, Alshammari SO, et al. Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression. PLOS One. 2025. doi:10.1371/journal.pone.0324060

BibTeX
@article{Zulfiqar2025,
  author = {Zulfiqar, Tayyaba and Tipu, Muhammad Khalid and Khan, Muhammad Tariq and Abouzied, Amr S and Al Kazman, Bassam S M and Alshammari, Saud O and Alshammari, Qamar A and Alshammari, Abdulkarim and Malik, Muhammad Nasir Hayat and Ali, Amir and Mazhar, Muhammad Usama and Jabeen, Hafsa},
  title = {Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324060}
}
Kostenlos starten →